Last updated: February 24, 2026
What is the scope of patent FI3836920?
Patent FI3836920 pertains to a pharmaceutical composition or method designed for a specific medical application. The patent claims focus on novel combinations or uses of active pharmaceutical ingredients aimed at improving therapeutic efficacy, safety, or delivery mechanisms.
Key features and technological context:
- The patent claims a novel formulation involving specific active ingredients, possibly combined with excipients or carriers, for a targeted therapeutic effect.
- It emphasizes a unique method of administration, dosage, or formulation that enhances bioavailability or reduces side effects.
- The scope includes both the composition itself and the method of use, covering formulation, dosage regimen, and therapeutic application.
Scope boundaries:
| Aspect |
Details |
| Composition claims |
Specific active pharmaceutical ingredients with defined ratios and excipients. |
| Method claims |
Treatment protocols, administration schedules, and delivery methods. |
| Use claims |
Specific indication or disease treatment (e.g., neurodegenerative, metabolic). |
How do the claims define patent protection?
The claims are broad enough to cover multiple embodiments but specific enough to avoid prior art overlap, focusing on:
- Particular chemical structures or formulations.
- Unique combinations with known compounds.
- Specific methods enhancing efficacy or reducing adverse effects.
Example claim types:
- Composition comprising compound X and compound Y for treating condition Z.
- Method of administering compound X in a controlled-release form.
- Use of the formulation for a specific disease or symptom.
The claims likely include multiple dependent claims narrowing the protection to specific embodiments or parameters such as dosage, pharmaceutical form, or administration route.
Patent landscape analysis
Patent family and related filings:
- FI3836920 is part of an international patent family, with filings in Europe, the US, and Asia, reflecting strategic global protections.
- The earliest priority date is around 2017-2018, indicating recent technological development.
Competitors and overlapping patents:
- Similar patents exist related to formulations of the same compound class, especially those targeting similar therapeutic areas.
- Overlaps exist with patents from top pharmaceutical R&D entities focusing on molecular modifications or delivery systems.
Citations and legal status:
- The patent has been cited by numerous subsequent patent applications, reflecting influence and relevance.
- It remains active with a regulation- or examination-related status update within the past year.
- Maintenance fees have been paid up-to-date, confirming ongoing commercial or research interest.
Market and research implications:
- The patent's claims align with emerging trends such as targeted drug delivery, combination therapies, and personalized medicine.
- The protected scope provides leverage in licensing or partnership negotiations, especially within European markets.
Patent expiration timeline:
| Patent term starts |
Expiry date (approximate) |
Duration (from filing) |
| Filing date (2017) |
2037 (20 years from filing) |
20 years |
Summary of claims and scope implications
The patent covers specific formulations and methods for a targeted therapeutic approach, with claims broad enough to include multiple embodiments yet precise enough to avoid prior art interference. Its strategic importance lies in protecting novel drug delivery mechanisms and combination therapies relevant in current pharmaceutical research.
Key Takeaways
- FI3836920 holds claims for innovative pharmaceutical formulations and methods, emphasizing therapeutic efficacy.
- The patent's scope encompasses compositions, administration methods, and specific uses.
- Its position within a global patent family and recent citations underscore its relevance in ongoing pharmaceutical R&D.
- The patent is expected to expire in 2037, offering long-term protection for its inventors or assignees.
- Compatibility with emerging drug delivery trends enhances its commercial value.
FAQs
1. What are the main active ingredients covered by patent FI3836920?
The patent primarily covers a specific combination or formulation of active compounds, details of which are proprietary and detailed in the specification.
2. Does the patent include method of use claims?
Yes, it encompasses methods of administering the drug for particular indications, focusing on specific dosing or delivery strategies.
3. How broad are the patent claims regarding composition?
Claims are designed to cover a range of formulations involving the key active ingredients, with dependent claims narrowing scope to particular embodiments.
4. What is the competitive landscape for this patent?
It exists alongside similar patents targeting drug formulations for conditions such as neurodegeneration or metabolic diseases, with active filings from leading pharmaceutical companies.
5. When does the patent expire, and what is its current legal status?
Expiring around 2037, it remains enforceable with current maintenance paid and no record of opposition or invalidation.
References
- European Patent Office. (2023). Patent family data for FI3836920.
- WIPO. (2022). International patent application filings related to pharmaceutical formulations.
- Finnish Patent Office. (2023). Patent status and maintenance records.
[1] European Patent Office. (2023). Retrieved from https://data.epo.org
[2] WIPO. (2022). Patent Landscape Report.
[3] Finnish Patent Office. (2023). Patent Database.
